Allergy Therapeutics Plc

Allergy Therapeutics (AGY)

Company name:Allergy Therapeutics Plc
EPIC:AGYTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00B02LCQ05
Market Segment:ASQ1Share Type:DE
WWW Address:Description:ORD 0.1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 11.75 uk.advfn.com/p.php?gfx=/gb/dot 0.0 [0.00] 11.50 12.00 11.75 11.75 11.75 33,940
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 75.68 644.12 -0.00 -1.27 - - - 18.00 - 7.35

Allergy Therapeutics Key Figures

(at previous day's close)
Market Cap.75.68m
Shares In Issue644.12m
Prev. Close11.75
PE Ratio- 
Dividend Yield-%
EPS - basic-1.27p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.59p
Return On Equity (ROE)-32.70%
Operating Margin-10.09%
PEG Factor- 
EPS Growth Rate-202.38%
Dividends PS Growth Rate-%
Net Debt12.45m
Gross Gearing54.85%
Quick Assets22.12m
Net Working Capital16.30m
Intangibles / Fixed Assets24.64%
Turnover PS10.61p
Pre-Tax Profit PS-1.07p
Retained Profit PS-1.17p
Cash PS2.41p
Net Cash PS0.14p
Net Tangible Asset Value PS *2.81p
Net Asset Value PS3.58p
Spread0.50 (4.17%) 

Allergy Therapeutics Balance Sheet

LSE:AGY:Liabilities+EQLSE:AGY:Assets

Share Price Performance

Sample Period HighLow
1 week12.1511.50
4 weeks13.7511.50
12 weeks13.7511.00
1 year18.007.35

Share Price Chart (5 years)

Allergy Therapeutics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week12.15-0.40-3.2911.500.1011.75
4 weeks13.25-1.50-11.3211.500.0712.24
12 weeks11.75--11.000.2811.62
26 weeks9.652.1021.768.504.6111.05
1 year17.60-5.85-33.247.352.6611.21
3 years24.50-12.75-52.047.351.0513.65
5 years17.75-6.00-33.807.350.7114.73

Allergy Therapeutics Key Management Ratios

Allergy Therapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.40 
Tobin's Q Ratio (excl. intangibles)1.55 
Dividend Yield-%
Market-to-Book Ratio3.29 
Price-to-Pre-Tax Profit PS-10.98 
Price-to-Retained Profit PS-10.05 
Price-to-Cash Flow PS-19.91 
Price-to-Sales PS1.11 
Price-to-Net Tangible Asset Value PS4.18 
Price-to-Cash PS4.87 
Net Working Capital PS2.53 
Price Pct to Working Capital PS4.64%
Earnings Yield-%
Average PE593.75 
Years in average2 
PE to PE average-%

Allergy Therapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio36.69%
Debt-to-Equity Ratio0.58 
Debt-to-Equity Ratio (excl. Intgbl)0.74 
Debt-to-Equity Market Value0.18 
Net Gearing24.40%
Net Gearing (excl. Intangibles)27.02%
Gross Gearing54.85%
Gross Gearing (excl. Intangibles)60.74%
Gearing Under 1 Year28.68%
Gearing Under 1 Year (excl. Intgbl)31.76%
Assets/Equity2.21 
Cash/Equity67.44 
(Liquidity Ratios)
Net Working Capital to Total Assets31.94%
Current Ratio2.11 
Quick Ratio (Acid Test)1.51 
Liquidity Ratio1.06 
Cash & Equiv/Current Assets50.22%
(Solvency Ratios)
Enterprise Value73.50m
CFO/Sales-0.06 
CFO/Attributable Profit- 
CFO/Assets-0.07 
CFO/Debt-0.14 
Total Debt/Equity Market Value0.37 
Total Debt/Sales0.41 
Total Debt/Pre-Tax Profit-4.06 
Total Debt27.98m
Total Debt/Net Current Assets1.72%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-17.84%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-21.50%
Earn drops > 5% in 10yrs7 
Beta (60-Mnth)Beta (36-Mnth)
-0.00150.0215

Allergy Therapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-18.95%
Return On Assets (ROA)-13.92%
Net Profit Margin-11.02%
Assets Turnover1.26 
Return On Equity (ROE)-32.70%
Return On Investment (ROI)-18.94%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-11.02%
(Asset Utilisation Multiples)
Shareholders Equity Turnover2.58 
Fixed Assets Turnover3.43 
Current Assets Turnover2.00 
Net Working Capital Turnover 
Inventory Turnover8.39 
(Other Operating Ratios)
Total Assets-to-Sales0.79 
Debtors-to-Sales10.56%
Debt Collection Period38.56Days

Allergy Therapeutics Dividends

Sorry No Data Available

Allergy Therapeutics Fundamentals

 30 Jun 2015 (GBP)30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)
turnover43.23100.00%48.51100.00%64.14100.00%68.35100.00%m
pre tax profit0.651.51%-12.06-24.87%-1.97-3.07%-6.90-10.09%m
attributable profit0.110.25%-13.07-26.95%-2.48-3.87%-7.53-11.02%m
retained profit0.110.25%-13.07-26.95%-2.48-3.87%-7.53-11.02%m
eps - basic (p)0.02 -2.29 -0.42 -1.27 
eps - diluted (p)0.02 -2.29 -0.42 -1.27 
dividends per share- - - - 

Allergy Therapeutics Balance Sheet

 30 Jun 2015 (GBP)30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)
LSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:Assets
 30 Jun 2015 (GBP)30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)
ASSETS
fixed assets fixed assets8.7517.26%9.6717.06%9.6716.92%10.1019.79%m
intangibles intangibles5.009.86%5.369.45%5.469.55%4.959.70%m
fixed investments fixed investments3.947.78%4.057.14%4.598.03%5.049.89%m
current assets - other current assets - other--%--%--%--%m
stocks stocks6.7513.31%7.6913.57%7.4813.09%8.8117.27%m
debtors debtors5.069.98%6.5111.49%7.8513.73%6.5912.91%m
cash & securities cash & securities21.2041.81%23.4141.30%22.1238.69%15.5330.45%m
TOTAL50.70100%56.68100%57.18100%51.02100%m
LIABILITIES
creditors - short creditors - short7.4214.64%12.5222.09%14.0224.52%14.6328.68%m
creditors - long creditors - long8.8117.38%13.8424.41%13.2023.08%13.3526.17%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL16.2332.01%26.3646.50%27.2247.60%27.9854.85%m
EQUITY
ord cap, reserves ord cap, reserves34.4767.99%30.3253.50%29.9752.40%23.0345.15%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL34.4767.99%30.3253.50%29.9752.40%23.0345.15%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Allergy Therapeutics Cash Flow Statement

30 Jun 2015 (GBP)30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)
Operating CF2.01-11.840.18-3.80m
Pre-Financing CF-0.66-13.33-1.77-6.31m
Retained CF19.42-0.79-1.95-6.60m

Allergy Therapeutics Brokers

NameActivityTypeMnemonicCode
Nomura Code Securities LimitedMarket Maker(MMF)Broker/DealerCODECODCGB21
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MMF)Broker/DealerCANAHOARGB21001
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Piper Jaffray LtdMarket Maker(MMF)Broker/DealerPIPRPIPRGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
AGY
Allergy Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191023 12:39:12